azomycin has been researched along with Liver Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, F; Li, Y; Ma, M; Meng, T; Shang, X; Shi, K; Tian, Y; Yuan, H | 1 |
| Chen, J; Li, X; Li, Y; Li, Z; Ma, P; Nai, J; Qu, H; Song, Z; Tang, X; Wang, Z; Xin, H; Zhang, J | 1 |
| Gnabre, JN; Hsu, MH; Huang, RC; Hwu, JR; Mold, DE; Pao, KC; Unlu, I; Wu, SC | 1 |
| Kumar, P; Narain, R; Quan, S; Wang, Y; Zhou, A | 1 |
| Brayton, CF; Chapiro, J; Cornish, TC; Duran, R; Frangakis, C; Ganapathy-Kanniappan, S; Geschwind, JF; Gorodetski, B; Hart, CP; Lin, M; Mirpour, S; Pekurovsky, V; Reyes, J; Schernthaner, RE; Sun, JD | 1 |
| Crukley, C; Desjardins, L; Hadway, J; Lee, TY; Morrison, L; Stewart, E; Wang, Y | 1 |
| Brader, P; Carlin, S; Chun, YS; Fong, Y; Hricak, H; Ling, CC; Riedl, CC; Singh, P; Wen, B; Woo, Y; Zanzonico, PB | 1 |
| Batmunkh, E; Hori, H; Miyake, K; Nagasawa, H; Nishioka, M; Shimada, M; Sugimoto, K; Uto, Y | 1 |
| de Geus-Oei, LF; Heerschap, A; Kaanders, JH; Krabbe, PF; Lok, J; Oyen, WJ; Punt, CJ; Rijpkema, M; Ruers, T; van der Kogel, AJ; van Laarhoven, HW; Wiering, B | 1 |
| Heerschap, A; Kaanders, JH; Lok, J; Peeters, WJ; Punt, CJ; Rijken, PF; Ruers, TJ; van der Kogel, AJ; van Laarhoven, HW; Wiering, B | 1 |
| Asbell, SO; Leibel, SA; Order, SE; Rominger, CJ | 1 |
| Ash, DV; Smith, MR | 1 |
12 other study(ies) available for azomycin and Liver Neoplasms
| Article | Year |
|---|---|
A Hypoxia-Sensitive Drug Delivery System Constructed by Nitroimidazole and its Application in the Treatment of Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Hypoxia; Liver Neoplasms; Micelles; Nitroimidazoles; Polyethylene Glycols; Tumor Microenvironment | 2022 |
Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Catheterization; Cell Hypoxia; Chemoembolization, Therapeutic; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Liver Neoplasms; Microspheres; Nitroimidazoles; Phosphoramide Mustards; Rabbits | 2020 |
Hepatocellular carcinoma targeting agents: conjugates of nitroimidazoles with trimethyl nordihydroguaiaretic acid.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Masoprocol; Models, Molecular; Molecular Conformation; Nitroimidazoles; Structure-Activity Relationship | 2014 |
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanogels; Nitroimidazoles; Polyethylene Glycols; Polyethyleneimine; Radiation-Sensitizing Agents; Temperature; Theranostic Nanomedicine | 2015 |
Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Circulating Tumor DNA; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Ethiodized Oil; Humans; Liver Neoplasms; Nitroimidazoles; Phosphoramide Mustards; Rabbits; Tumor Hypoxia | 2017 |
Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Liver Neoplasms; Male; Neovascularization, Pathologic; Nitroimidazoles; Oxygen Consumption; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits | 2017 |
Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET.
Topics: Animals; Carcinoma, Hepatocellular; Hypoxia; Image Processing, Computer-Assisted; Iodine Radioisotopes; Liver Neoplasms; Monosaccharides; Nitroimidazoles; Positron-Emission Tomography; Rats; Rats, Nude | 2008 |
The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Liver Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous | 2008 |
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
Topics: Adult; Aged; Cell Hypoxia; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carbonic Anhydrases; Cell Hypoxia; Cell Proliferation; Colorectal Neoplasms; Female; Glucose Transporter Type 1; Humans; Idoxuridine; Liver Neoplasms; Male; Middle Aged; Nitroimidazoles | 2006 |
Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
Topics: Adult; Aged; Alkaline Phosphatase; Drug Evaluation; Female; Humans; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Misonidazole; Nitroimidazoles; Organ Size; Palliative Care; Time Factors | 1981 |
Causes of apparent low levels of misonidazole in human tumours.
Topics: Adipose Tissue; Animals; Brain Neoplasms; Humans; In Vitro Techniques; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Misonidazole; Muscles; Neoplasms; Nitroimidazoles; Rats | 1980 |